CSCL: Influence of Silicone Hydrogel Contact Lens Neophyte Wear on Corneal Sensitivity

Sponsor
Daniela Nosch (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05745220
Collaborator
(none)
42
1
1
5
8.4

Study Details

Study Description

Brief Summary

Soft contact lenses can affect the ocular surface and sometimes cause intolerance. The aim of this study is to measure corneal sensitivity using the Swiss Liquid Jet aesthesiometer at baseline, after one and after six weeks, in novice daily contact lens wearers.

Condition or Disease Intervention/Treatment Phase
  • Other: Device: silicone hydrogel contact lens
N/A

Detailed Description

Contact lens discomfort is described by many wearers. Wearing contact lenses can influence corneal sensitivity through three mechanisms: hypoxic, mechanical and inflammatory. A change in corneal sensitivity can be considered an indicator of a change in corneal physiology. Corneal sensitivity plays a major role in maintaining eye health. The interest of this study is to test the variability of the corneal sensitivity threshold during a new adaptation of silicone hydrogel contact lenses, and to verify whether there is a correlation with the wearer's comfort. For that, corneal sensitivity threshold measurements are taken at the baseline and then after one and six weeks of daily contact lens wear. The measurement is performed with the Swiss Liquid Jet aesthesiometer for corneal sensitivity (SLACS). After one week and six weeks of daily lens wear, participants complete a Contact Lens Dry Eye Questionnaire (CLDEQ-8) for comfort analysis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
42 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single Group AssignmentSingle Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Corneal Sensitivity in Silicone Hydrogel Contact Lens Wear
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Daily contact lens wear

Participant wear silicone hydrogel contact lenses daily for 6 weeks ±2 days for a minimum wearing time of 5 days per week and 8 hours per day - corneal sensitivity will be measured and compared at baseline versus after 7±2 days and 5 weeks ±2 days daily contact lens wear.

Other: Device: silicone hydrogel contact lens
Silicone hydrogel contact lens

Outcome Measures

Primary Outcome Measures

  1. Difference in corneal sensitivity threshold baseline and after one and six weeks of daily contact lens wear [7±2 days and 5 weeks ±2]

    Comparison of corneal sensitivity threshold at the baseline and after one and six weeks of daily wear of silicone hydrogel contact lenses on neophyte wearer. Corneal sensitivity measurement will take place with the Swiss Liquid Jet Aesthesiometer for Corneal Sensitivity (SLACS) and will be recorded in mbar.

Secondary Outcome Measures

  1. Correlation between corneal sensitivity threshold and subjective symptoms [7±2 days and 5 weeks ±2]

    Correlation between corneal sensitivity threshold and subjective symptoms after one and six weeks of daily contact lens wear: corneal sensitivity threshold will be determined with the Swiss Liquid Jet Aesthesiometer for Corneal Sensitivity (SLACS) and will be recorded in mbar. Subjective Symptoms will be recorded with the CLDEQ-8 questionnaire (specifically designed to assess contact lens comfort)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 38 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The Ocular Surface Disease Index questionnaire (OSDI) score for dry eye classification is ≤ 13

  • Participants must be candidates for contact lens wear.

  • Corneal radius between 7.4mm and 8.0mm

  • If the corneal radius is > 8.0mm, the corneal diameter must be greater than 12.0mm.

  • If the corneal radius is <7.4mm, the required corneal diameter is less than 12.0mm.

  • Participants have a CL cylindrical ametropia ≤ -1.25 D.

  • Participants will not have worn CL for 7 days prior to the start of the study.

  • Participants do not wear CL regularly (no more than 1 days per week) prior to the start of the study.

  • During the study, the participant wore the CL a minimum of 5 days per week for a minimum of 8 hours.

  • The person being tested is in good health. This means that he or she does not suffer from any systemic diseases, such as diabetes or rheumatism, which could have an influence on eye health. He or she also has no eye disease and has not previously undergone corneal (refractive) surgery.

Exclusion Criteria:
  • The participant is a minor.

  • The participant has worn CL within the last 7 days.

  • The radius of the cornea is not within the prescribed range. In addition, the corneal diameter is not within the prescribed range either.

  • The participant's ametropia is not within the prescribed range.

  • The participant has worn the lenses for less than 8 hours for less than five days.

  • The participant has no diagnosis of dry eye.

  • The OSDI questionnaire score for the Dry Eye classification is greater than 13.

  • The participant suffers from a systemic disease (diabetes or rheumatism) that could influence ocular health, an ocular disease or has already undergone refractive surgery.

  • Vulnerable participants

Contacts and Locations

Locations

Site City State Country Postal Code
1 Optique Messerli Optometry centre Marly Fribourg Switzerland 1723

Sponsors and Collaborators

  • Daniela Nosch

Investigators

  • Principal Investigator: Daniela Nosch, PhD, Institute of Optometry, FHNW

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Daniela Nosch, Clinical Professor, University of Applied Sciences and Arts Northwestern Switzerland
ClinicalTrials.gov Identifier:
NCT05745220
Other Study ID Numbers:
  • 2022-D0124
First Posted:
Feb 27, 2023
Last Update Posted:
Feb 27, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Daniela Nosch, Clinical Professor, University of Applied Sciences and Arts Northwestern Switzerland
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 27, 2023